Platform
Features
0 followers
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.
Industries
Headquarters
Employees
Links
Stefanie Flückiger-Mangual
Ferring Pharmaceuticals
13 followers
ETH Zürich
5 followers
Debiopharm
1 follower
Molecular Partners
2 followers
Roche
226 followers
AbbVie
156 followers
Solvias
Incyte
14 followers
Novavax
7 followers
Recursion Pharmaceuticals
6 followers
Coca-Cola HBC
9 followers
Discover companies